Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
April 2, 2026 Drug delivery / Pharma applications

Cyclodextrin and KR12-Lipopeptide Interactions

Natural antimicrobial peptides are a promising new class of antibiotics that offer a potential response to the growing challenge of

Continue reading

April 1, 2026 CD derivatives / Drug delivery / Pharma applications

Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.

Oral drug delivery is a vital route because it is easy to administer, which improves patient compliance and allows for

Continue reading

March 31, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Researchers in Japan have developed a promising new drug delivery platform that not only carries medicines directly to bone, but

Continue reading

May 30, 2019 CD as API / CD derivatives

Lactosyl-β-cyclodextrin against Hepatomegaly in Niemann-Pick Type C Disease

The first paper in the special issue of Nanomaterials “Nanoconstructs Based on Cyclodextrins” has been published. Mono-lactosyl β-CD (mono-Lac-β-CD) diminished

Continue reading

May 28, 2019 E-ducation

Carbohydrate drugs (Part 4) (Oligosaccharides, antibiotics)

In the next two posts we’ll take a closer look to the oligosaccharides (generally composed from 3 to 10 monosaccharide

Continue reading

May 24, 2019 Events

Abstract submission for EuroCD 2019 Deadline extended: 15 June

The 6th European Cyclodextrin Symposium will be held on October 2-4, 2019 in Santiago de Compostela. The main organizer is

Continue reading

May 22, 2019 E-ducation

Carbohydrate drugs (Part 3) (Disaccharides)

In the previous posts we talked a little bit about monosaccharide type active pharmaceutical ingredients. The next are disaccharides: composed of

Continue reading

May 20, 2019 Food

CD-enabled natural antimicrobial composition for food

   Epolyly ® CD ε-Polylysine + β-Cyclodextrin   Epolyly® CD is a natural antimicrobial composition of ε-polylysine and β-Cyclodextrin, effective

Continue reading

May 18, 2019 Events

BIO International Convention in Philadelphia

BIO 2019 gives opportunity for 16000+ biotechnology and pharma leaders to come together for one week of intensive networking on

Continue reading

May 15, 2019 E-ducation

Carbohydrate drugs (Part 2) (iminosugars and rare diseases)

  In the part 1 we talked about monosaccharides used for the treatment of common diseases, like influenza or angina

Continue reading

May 13, 2019 E-ducation

Carbohydrate drugs (Part 1)

As we know, cyclodextrins are composed of α-D-glucopyranose units. Among pharmaceuticals there are several other carbohydrate type drugs. In this

Continue reading

May 13, 2019 Drug delivery / Pharma applications

The Use of ADV6209 for Premedication in Pediatric Anesthesia

A recently posted phase 2 clinical trial (not yet recruiting) aims to evaluate the effect of ADV6209, a new oral

Continue reading

May 10, 2019 Drug delivery / Pharma applications

Axsome Therapeutics Announces Acceleration of MOMENTUM Phase 3 Trial of AXS-07 in Migraine

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today

Continue reading

Posts pagination

«Previous Posts 1 … 179 180 181 182 183 … 194 Next Posts»

Recent Posts

  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (339)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (128)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (389)
  • Other industrial use (103)
  • Pharma applications (1,156)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Renal safety of SBECD
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • How air fresheners work?
  • Recent papers on Cyclodextrins in Nature
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Phase III Results of Adamgammadex
  • Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients
  • Lanosterol eye drops for cataract treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...